Today I sorted the S&P 500 Large Cap Index stocks to find the 3 with the best Barchart technical indicators and found Zion Bancorporation (ZION), Watson Pharmaceuticals (WPI) and Wal-Mart Stores (WMT):

Zion Bancorporation (ZION)

Barchart technical indicators:

• 100% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 7 new highs and up 13.53% in the last month
• Relative Strength Index 72.74%
• Barchart computes a technical support level at 21.59
• Recently traded at 21.98 with a 50 day moving average of 19.78

Watson Pharmaceutical (WPI)

Barchart technical indicators:

• 100% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 9 new highs and up 5.77% in the last month'
• Relative Strength Index 73.97%
• Barchart computes a technical support level at 86.55
• Recently traded at 87.86 with a 50 day moving average of 81.80

Wal-Mart Stores (WMT)

Barchart technical indicators:

• 100% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 3 new highs and up 2.15% in the last month
• Relative Strength Index 60.88%
• Barchart computes a technical support level at 74.56
• Recently traded at 75.13 with a 50 day moving average of 73.71

Watson Phamaceutical - WPI - Barchart Chart of the Day

Barchart.coms Chart of the Day - Watson Pharmaceuticals (WPI) Barchart Research Team - BC - Thu Sep 20, 4:18PM CDT The "Chart of the Day" is Watson Pharmaceuticals (WPI), which showed up on Thursday's Barchart "All-Time High" list. Watson on Thursday posted a new all-time high of $84.36 and closed +0.59%. TrendSpotter took a profit on a long trade last Friday and then gave a new buy signal on Wednesday. In recent news on the stock, Guggenheim on Sep 18 initiated coverage on Watson with a Buy and a target of $100. Goldman on Sep 11 downgraded Watson to Buy from Conviction Buy due to valuation but raised its target to $95 from $90. Watson Pharmaceuticals, with a market cap of $10 billion, is a pharmaceutical company primarily engaged in the development and sale of both branded and off-patent pharmaceutical products. How we found the Chart of the Day: We found the "Chart of the Day" by scanning the Barchart "All Time High" list. In order to get to that list, we first clicked on the Stocks menu item on the Barchart home page, then on the "All Time Highs" menu item on the left menu bar. We then sorted the list by percentage gainers by clicking on the "Percent" column title. A stock that has posted a new All-Time high is typically showing strong upside momentum. The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report. TrendSpotter: Buy Short-Term Indicators: 80% Buy Medium-Term Indicators: 100% Buy Long-Term Indicators: 100% Buy Overall Average 96% Buy Barchart links for further information: Quotes and Charts Quote Detailed Quote Chart Technical Analysis Technicals Summary Trader's Cheat Sheet™ Barchart Opinions Barchart Opinion Barchart Snapshot Trading Strategies Company Info Company Profile Key Statistics Ratios Income Statement-Quarterly Income Statement-Annual Balance Sheet-Current Balance Sheet-Annual Chart of the Day Archive View Past Chart of the Day Reports

3 Growth Stocks with Momentum

Today I took a list of stocks I found that analysts project will have a 10% increase in revenue, earnings and total return to investors and ran them through the Barchart screener to find those with good current momentum and technicals and found RPC (RES), Watson Pharmaceuticals (WPI) and Genesee & Wyoming (GWR).

RPC (RES)

Barchart technical indicators:

• 100% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 9 new highs and up 30.01% in the last month
• Relative Strength Index 68.94%
• Barchart computes a technical support level at 11.51
• Recently traded at 13.15 with a 50 day moving average of 11.10

Watson Pharmaceutical (WPI)

Barchart technical indicators:

• 88% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 11 new highs and up 8.91% in the last month
• Relative Strength Index 64.04%
• Barchart computes a technical support level at 73.76
• Recently traded at 77.50 with a 50 day moving average of 72.55

Genesee & Wyoming (GWR)

Barchart technical indicators:

• 88% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving average
• 13 new highs and up 19.78% in the last month
• Relative Strength Index 68.83%
• Barchart computes a technical support level at 57.19
• Recently traded at 60.05 with a 50 day moving average of 52.64

 

5 Large Cap S&P 500 stocks still going up

This morning I used Barchart to screen the Large Cap S&P 500 stocks to find 5 that were still moving against the tide.  I found Sempra Energy (SRE), Watson Pharmaceuticals (WPI), Chubb Corp (CB), PPG Industries (PPG), and Kimberly Clark (KMB) still looking pretty good.

Sempra Energy (SRE)

Barchart technical indicators:

• 88% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 13 new highs and up 9.17% in the last month
• Relative Strength Index 62.74%
• Barchart computes a technical support level at 63.02
• Recently traded at 63.51 with a 50 day moving average of 59.83

Watson Pharmaceuticals (WPI)

Barchart technical indicators:

• 96% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 11 new highs and up 5.76% in the last month
• Relative Strength Index 69.15%
• Barchart computes a technical support level at 67.86
• Recently traded at 69.03 with a 50 day moving average of 62.61

Chubb Corp (CB)

Barchart technical indicators:

• 88% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving average
• 11 new highs and up 4.84% in the last month
• Relative Strength Index 57.82%
• Barchart computes a technical support level at 70.49
• Recently traded at 71.03 with a 50 day moving average of 69.04

PPG Indudtries (PPG)

Barchart technical indicators:

• 96% Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 10 new highs and up 6.74% in the last month
• Relative Strength Index 62.28%
• Barchart computes a technical support level at 99.36
• Recently traded at 100.16 with a 50 day moving average of 94.04

Kimberly Clark (KMB)

Barchart technical indicators:

• Barchart technical buy signal
• Trend Spotter buy signal
• Above its 20, 50 and 100 day moving averages
• 10 new highs and up 4.59% in the last month
• Relative Strength Index 73.71%
• Barchart computes a technical support level at 75.30
• Recently traded at 76.50 with a 50 day moving average of 73.16

Barchart Morning Call 2/14

Barchart Morning Call

Barchart.com - 2 hrs 58 mins ago

Overnight Developments

• Global stocks this morning are mostly higher with the Euro Stoxx 50 up +0.14% and Mar S&Ps up +1.90 points. Stocks and commodities moved higher, with Mar crude at a 3-week high, after German investor confidence unexpectedly jumped to a 10-month high and as Italian and Spanish borrowing costs fell, even after Moody's Investors Service downgraded the debt ratings of 6 European countries. The dollar index retreated from a 1-week high after the Feb German ZEW survey of economic sentiment surged +27.0 to 5.4, stronger than expectations of +9.6 to -12.0. Stocks had earlier declined after Moody's Investors Service Downgraded Spain's debt rating to A3 from A1, Italy to A3 from A2 and Portugal to Ba3 from Ba2, all with negative outlooks. Slovakia, Slovenia and Malta also had their ratings cut, while Moody's said it may also strip France and the U.K. of their top Aaa ratings, citing Europe's debt crisis. The euro recovered from early losses and moved higher after Italian and Spanish borrowing costs fell when Italy sold 6 billion euros of bonds, the maximum target, with the yield on the 2-year securities at 3.41%, down from a similar auction last month at 4.83% and the lowest in 11 months, while Spain sold 5.45 billion euros of bills with a yield on the 12-month debt at 1.899%, down from 2.049% at a similar auction in Jan and the lowest in 16 months.
• Asian stocks today closed mixed with Japan up +0.59%, China -0.39%, Australia -0.99%, South Korea -0.14%, India +0.43%. Asian stocks had weakened after Moody's downgraded the debt ratings of 6 European nations but Japan's Nikkei 225 Stock Index shed its losses and rallied up to a 3-1/2 month high when the BOJ unexpectedly added 10 trillion yen ($128 billion) to an asset-purchase program and said it will target 1% inflation "for the time being." The BOJ boosted its bond-purchase program to 65 trillion yen ($835 billion) from 55 trillion yen and said in a statement that it aimed to "clarify its monetary policy stance" and wants to "overcome deflation and achieve sustainable growth with price stability." The yen fell to a 2-1/2 week low against the dollar following the BOJ's actions, which fueled gains in banks and exporters.

Overnight U.S. Stock News

• March S&Ps this morning are trading up +1.90 points. The US stock market on Monday settled higher on reduced European sovereign debt concerns after Greece approved austerity measures needed to secure bailout funds: Dow Jones +0.57%, S&P 500 +0.68%, Nasdaq Composite +0.95%. The Nasdaq posted a fresh 11-year high. Bullish factors included (1) carry-over strength from a rally in European stocks after Greece's parliament approved austerity measures needed to ensure that it receives a second bailout package to keep it from default, (2) reduced concerns of a European liquidity crisis after the Euribor-OIS spread, a measure of European banks' reluctance to lend, dropped to 71 bp, the lowest in 4 months, (3) speculation China may ease its monetary policies further to stimulate growth after Chinese Premier Wen Jiabao said the nation needs to start "fine-tuning" economic policies this quarter, and (4) a rally in commodity and energy producers as a weaker dollar helped spur gains in most commodities.
• Bearish factors Monday included (1) concern that weak economic growth in Asia may slow the global economy after Q4 Japan GDP contracted -0.6% q/q and -2.3% annualized, weaker than expectations of -0.3% q/q and -1.3% annualized and (2) a joint 173-page letter from the Clearing House Association, American Bankers Association, Securities Industry and Financial Markets Association and the Financial Services Roundtable that said the proposed Volcker Rule to ban propriety trading would "severely limit banking entities' ability to hedge their own risk, thereby increasing rather than decreasing the risk to banking entities and the financial system."

Today's Market Focus

• March 10-year T-notes this morning are up +2.5 ticks. T-note prices on Monday settled lower but well off of their worst levels on concern that Greek approval of austerity steps taken to receive its second bailout will be insufficient in ending the country's debt crisis: TYH2 -8.5, FVH2 -5.7, EDM2 -1.5. Bearish factors Monday included (1) reduced safe-haven demand for Treasuries after global stocks rallied when Greece's parliament approved austerity measures needed to ensure that it receives a second bailout package to keep it from default and (2) reduced concerns of a European liquidity crisis, which also dented safe-haven demand for Treasuries, after the Euribor-OIS spread, the difference between the euro interbank offered rate and overnight indexed swaps and a measure of European banks' reluctance to lend, dropped to 71 bp, the lowest in 4 months. Bullish factors included (1) the Fed's action to purchase $1.813 billion of Treasuries as part of its Operation Twist program to replace $400 billion of short-term debt in its portfolio with longer-term Treasuries in an effort to keep borrowing costs low, (2) skepticism that Greece's action to approve austerity measures needed for a second bailout will be enough to end the country's sovereign-debt crisis, and (3) comments from San Francisco Fed President Williams who said "there may still be considerable scope" for the Fed's monetary policy to affect medium and longer-term interest rates, even when the target for overnight lending rates is near zero.
• The dollar index this morning is lower with the dollar/yen +0.51 yen and the euro/dollar +0.08 cents. The dollar index on Monday settled lower but well off its worst levels on concern that Greek approval of austerity measures will still be insufficient to keep it from default: Dollar Index -0.168, USDJPY -0.062, EURUSD -0.00111. Bearish factors included (1) reduced safe-haven demand for the dollar after global stock markets rallied when Greece's parliament approved austerity measures needed to ensure that it receives a second bailout package to keep it from default, (2) the statement from EU Economic and Monetary Affairs Commissioner Rehn that he's "confident" that Greece has done enough to ensure it receives the bailout, and (3) the decline in Italian borrowing costs to their lowest in 8 months after Italy sold Treasury bills at the maximum target of 12 billion euros, which is euro supportive. Bullish factors Monday included (1) the weaker than expected Q4 Japan GDP, which is yen negative and (2) concern that Greek approval of austerity measures for financial aid will be insufficient to stem the Greek sovereign-debt crisis.
• Mar crude oil prices this morning are up +59 cents a barrel at a 3-week high and Mar gasoline is cents per gallon. Crude oil and gasoline prices Monday moved higher after the Greek parliament approved an austerity plan to receive financial aid, which reduced European debt concerns, and also after shippers said they will stop loading crude cargoes from Iran, which may limit global crude supplies: CLH12 +$2.24, RBH +3.76. Mar crude posted a 1-1/2 week high and Mar gasoline climbed to a 5-1/2 month high. Bullish factors included (1) the weaker dollar, which encourages investment demand in commodities, (2) the action by Greece's parliament to approve austerity measures needed to ensure a 130-billion-euro aid package, which reduces concern Greek will default on its debt and undercut the global economy and energy demand, (3) the statement from the Overseas Shipholding Group, Frontline Ltd. and owners that control more than 100 supertankers, that because of the EU's upcoming ban on Iranian crude oil in July, they will stop loading crude cargoes from Iran, which may curtail global crude supplies, and (4) strength in gasoline on concern the closure of several East Coast refineries will limit gasoline supplies as DOE data showed the U.S. East Coast processed 903,000 barrels of oil a day in the week ended Feb 3, down from 1.11 million a year earlier. A bullish factor was the bigger-than-expected contraction in Q4 Japan GDP, which signals reduced energy demand in the world's third-largest crude oil consumer.

Today's U.S. Earnings Reports Earnings reports (confirmed releases, sorted by mkt cap): MET-MetLife (BEST earnings consensus $1.24), MMC-Marsh & McLennan (0.45), HCP-HCP Inc. (0.46), OMC-Omnicom Group (0.94), FTI-FMC Technologies (0.84), HST-Host Hotels & Resorts (0.03), ZNGA-Zynga (0.03), BWA-BorgWarner (1.17), AVP-Avon Products (0.53), WPI-Watson Pharmaceuticals (1.76), WSH-Willis Group Holdings PLC (0.48), KORS-Michael Kors Holdings Ltd. (0.06), FOSL-Fossil (1.77), HSP-Hospira (0.47), WTW-Weight Watchers International (0.86), GT-Goodyear Tire & Rubber (0.21).
Global Financial Calendar

Tuesday 2/14/12
United States
0745 ET	ICSC (Int?l Council of Shopping Centers) weekly retailer sales.
0830 ET	Jan import price index expected +0.3% m/m and +7.2% y/y, Dec -0.1% m/m and +8.5% y/y.
0830 ET	Jan retail sales expected +0.8% and +0.5% less autos, Dec +0.1% and -0.2% less autos.
0845 ET	Philadelphia Fed President Charles Plosser speaks on the economic outlook at an event in Newark, DE.
0855 ET	Redbook weekly retailer sales.
1000 ET	Dec business inventories expected +0.4%, Nov +0.3%.
1000 ET	Treasury Secretary Timothy Geithner testifies before the Senate Finance Committee on the president?s budget for fiscal 2013.
1130 ET	Weekly 4-week T-bill auction.
1740 ET	Atlanta Fed President Dennis Lockhart speaks on the economic outlook to the Global Independence Center in Sarasota, FL.
France
0245 ET	Q4 French non-farm payrolls expected -0.3% q/q, Q3 unchanged q/q. Q4 French wages, Q3 +0.3% q/q.
United Kingdom
0430 ET	Dec U.K. DCLG house prices, Nov -0.3% y/y.
0430 ET	Jan U.K. CPI expected -0.5% m/m and +3.6% y/y, Dec +0.4% m/m and +4.2% y/y.
0430 ET	Jan U.K. core CPI expected +2.6% y/y, Dec +3.0% y/y.
0430 ET	Jan U.K. RPI expected -0.4% m/m and +4.1% y/y, Dec +0.4% m/m and +4.8% y/y.
0430 ET	Jan U.K. RPI ex-mortgage interest payments expected +4.2% y/y, Dec +5.0% y/y.
Germany
0500 ET	Feb German ZEW survey economic sentiment expected +9.6 to -12.0, Jan +32.2 to -21.6. Feb ZEW survey current situation expected +2.1 to 30.5, Jan +1.6 to 28.4.
Euro-Zone
0500 ET	Dec Euro-Zone industrial production expected -1.2% m/m and -1.2% y/y, Nov -0.1% m/m and +0.1% y/y.

Barchart.com provides Financial Quotes, Charts and Technical Analysis for Stock and Commodity Traders.

Watson Pharmaceuticals - Barchart Chart of the Day

Barchart.coms Chart of the Day - Watson Pharmaceuticals (WPI)

Barchart Research Team - Barchart.com - Tue Jun 28, 7:05PM CDT

Related Stocks

WPI - Watson Pharmaceuticals

Sym	Last	Chg	Pct
WPI	68.20	+2.75	+4.20%

The "Chart of the Day" is Watson Pharmaceuticals (WPI), which showed up on Tuesday's Barchart "NYSE 12-month high" list. WPI rallied up to a 10-3/4 year high Tuesday of $68.29 and finished the day up +4.2%. WPI now has its sights set on the all-time high of $71.50 posted back in Sep 2000. Trendspotter (tm) has been long WPI for the past 2-1/2 months at a price of $54.81 as WPI has been in a steady uptrend for the past 2-1/2 years. On Tuesday, the U.S. District Court in Delaware ruled in favor of WPI against Endo Pharmaceutical, which is trying to defend the patents on its Lidoderm pain patch. WPI is hoping to market its own generic version of Lidoderm and the court's ruling today could hurt Endo's position as the companies prepare to go to trial in February. Jefferies & Co. analyst Corey Davis said the judge found that the disputed patent covered only one of a group of ingredients, as Watson had argued, while Endo argued the patent covered one or more ingredients. Davis said that if Watson's generic is approved, it will probably not reach the market until mid-2013 at the earliest. Watson Pharmaceuticals, with a market cap of $8.304 billion is a pharmaceutical company primarily engaged in the development, production, marketing and distribution of both branded and off-patent pharmaceutical products. The company's branded pharmaceutical business operates primarily in three specialty areas: Dermatology, Women's Health and General Products. The company's products include therapeutic and preventive agents generally sold by prescription or over-the-counter for the treatment of human diseases and disorders.


How we found the Chart of the Day:
We found the "Chart of the Day" by scanning the Barchart "New Highs/Lows" page. Then we clicked on the entry for NYSE 12-month highs. A new 12-month high is a popular sign of upside momentum. Then we applied a "Custom View" heading with the Barchart Opinion ranking as one of the columns. we then sorted the list by the Barchart Opinion ranking in order to find the stocks with the highest Opinion.
Barchart's Opinion trading systems are mostly a Buy and Barchart's daily Trendspotter(tm) trading system is a "Buy." Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

• Trendspotter: Buy
• Short-Term Indicators: 100% Buy
• Medium-Term Indicators: 100% Buy
• Long-Term Indicators: 100% Buy
• Overall Average 100% Buy

---

Barchart links for further information:

Quotes and Charts
Quote
Detailed Quote
Chart

Technical Analysis
Technicals Summary
Trader's Cheat Sheet™

Barchart Opinions
Barchart Opinion
Barchart Snapshot
Trading Strategies

Company Info
Company Profile
Key Statistics
Ratios
Income Statement-Quarterly
Income Statement-Annual
Balance Sheet-Current
Balance Sheet-Annual

---

Chart of the Day Archive
View Past Chart of the Day Reports

Growth in generic drugs

Financial Tides likes Watson Pharmaceuticals, Inc. ( WPI ) a pharmaceutical company primarily engaged in the development, production, marketing and distribution of both branded and off-patent pharmaceutical products. The company's branded pharmaceutical business operates primarily in three specialty areas: Dermatology, Women's Health and General Products. The company's products include therapeutic and preventive agents generally sold by prescription or over-the-counter for the treatment of human diseases and disorders.


The big story is in the acquisition of the Arrow Group. Although the acquisition required the issuance of 17 million shares that dilutes earning per share, overall sales should benefit because it will allow the company to enter new over seas markets. Growth will come in new offerings of generic drugs in the areas of urology, birth control and a new generic version of Lipitor one of the largest selling brand names on the planet.


This is a momentum play and the stock hit 6 new highs in the last 30 days even in this soft market. The growth in price has been steady so it earned a 100% overall Barchart buy signal having buy signals on all 13 technical indicators. The stock appreciated 2.58% in the last 30 days and trades around 43.73 with a 50 day moving average of 42.18.

Investor sentiment is high as measured on Motley Fool with the CAPS members voting 148 to 17 that the stock will beat the market. The All Stars have similar feelings with a vote of 55 to 4.

Wall Street analysts have noticed this stock and have 5 buy and 9 hold reports published. They look for double digit growth in both sales and earnings. Sales are predicted to increase 25.80% this year and 11.10% next year. Earnings growth is forcasted to be 25.20% this year, 11.50% next year and a 5 year compounded growth rate of 10.42% annually.

This stock deserves your attention because:

• The acquisition of Arrow group opens new foreign markets for distribution


• New offerings of generic drugs are coming on line


• Barchart technical indicators have recognized solid and consistent price appreciation with a 100% over all technical buy signal


• Investor sentiment is positive


• Fundamental Wall Street analysts have predicted double digit increases in sales and earnings

Jim Van Meerten is an investor who writes on investing on Financial Tides and Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: No positions in WPI at the time of publication

Other analyses by the same author:

Baidu -- BIDU

VeriSign -- VRSN

Chico's -- CHS